SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-011844
Filing Date
2021-02-03
Accepted
2021-02-03 21:50:48
Documents
1
Period of Report
2021-02-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm215262-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm215262-2_4seq1.xml 4 4264
  Complete submission text file 0001104659-21-011844.txt   5690
Mailing Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452
Business Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452 781-788-9043
EYEGATE PHARMACEUTICALS INC (Issuer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EYEGATE PHARMACEUTICALS, INC. 271 WAVERLEY OAKS ROAD, SUITE 108 WALTHAM MA 02452
Business Address
Obermayr Franz (Reporting) CIK: 0001843571 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36672 | Film No.: 21588629